A18.17 is a billable and specific ICD-10-CM code. Accurate documentation of A18.17 facilitates proper diagnosis, effective management, and correct reimbursement.
This guideline will provide the use, official coding guidelines, and historical background of A18.17.
What is the ICD-10-CM Diagnosis Code for Tuberculous female pelvic inflammatory disease?
The ICD-10-CM diagnosis code for Tuberculous female pelvic inflammatory disease is A18.17.
Pelvic inflammatory disease (PID) is an infection of the female reproductive organs, including the uterus, fallopian tubes, and ovaries.
Tuberculous female pelvic inflammatory disease is a rare form of PID caused by Mycobacterium tuberculosis. It usually spreads from the lungs through blood or lymph.
This condition may develop slowly and often goes undiagnosed for a long time. Symptoms may include pelvic pain, irregular menstrual bleeding, vaginal discharge, fever, and infertility.
Diagnosis involves imaging, lab tests, or biopsy. Treatment requires long-term anti-tuberculosis medications. Early detection helps prevent complications and improves reproductive health.
Proper documentation using A18.17 ensures patients receive appropriate care and enables accurate healthcare reimbursement.
History Background of ICD-10-CM Diagnosis Code A18.17
The ICD-9-CM system, first introduced in 1979, provided the initial framework for coding diseases and health-related conditions in the United States.
The ICD-9-CM diagnosis code for Tuberculous female pelvic inflammatory disease is 016.70.This coding remained consistent from 1979 to 2015.
While the ICD-9-CM system offered a basic approach to disease classification, modern healthcare needs more detail and specificity.
To address this, the ICD-10-CM system was launched in 2015, introducing a more comprehensive and accurate coding structure.
The transition from ICD-9-CM to ICD-10-CM significantly improved the ability to document and analyze conditions such as Tuberculous female pelvic inflammatory disease.
The 2025 edition of ICD-10-CM A18.17 became effective on October 1, 2024.
| Year | ICD-10-CM Code | Description |
| 2020 | A18.17 | No Change |
| 2021 | A18.17 | No Change |
| 2022 | A18.17 | No Change |
| 2023 | A18.17 | No Change |
| 2024 | A18.17 | No Change |
| 2025 | A18.17 | No Change |
Final Thought
Proper coding of A18.17 is essential for diagnosing and managing Tuberculous female pelvic inflammatory disease. A clear understanding of its History, and correct usage enhances medical documentation and ensures effective treatment, patient care, supports healthcare planning, and guarantees proper reimbursement for medical services.
